Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone
Matzkies, F.
Fortschritte der Medizin 101(20): 953-959
1983
ISSN/ISBN: 0015-8178 PMID: 6873850 Document Number: 197197
Document emailed within 1 workday
Related Documents
Ohno, I.; Okabe, H.; Yamaguchi, Y.; Saikawa, H.; Uetake, D.; Hikita, M.; Gomi, H.; Ichida, K.; Hosoya, T. 2008: Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol Nihon Jinzo Gakkai Shi 50(4): 506-512Nitsche, V.; Mascher, H. 1981: Determination of benzbromarone in serum following combined therapy with allopurinol and benzbromarone Arzneimittel-Forschung 31(3): 510-512
Akkasilpa, S.; Osiri, M.; Deesomchok, U.; Avihingsanon, Y. 2004: The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia Journal of the Medical Association of Thailand 87(9): 1087-1091
Mangini, R.J. 1979: Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout American Journal of Hospital Pharmacy 36(4): 497-504
Schräpler, P.; Kleinschmidt, A.; Haese, E. 1978: The effect of benzbromarone on fasting-hyperuricemia as a model Medizinische Klinik 73(23): 861-866
Kitamura, T.; Maruyama, T.; Nakamura, H.; Hayashi, K.; Shigehira, M.; Iwaki, Y.; Okamoto, T.; Ishikawa, T.; Ishinoda, Y.; Kisanuki, H. 1990: Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Part 1): 1467-1471
Walter-Sack, I.; de Vries, J.X.; von Bubnoff, A.; Pfleilschifter, V.; Raedsch, R. 1995: Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites? European Journal of Medical Research 1(1): 16-20
Gao, H. 2019: Clinical efficacy and safety of benzbromarone in elderly hypertensive patients with hyperuricemia Pakistan Journal of Pharmaceutical Sciences 32(4 Supplary): 1869-1871
Kawenoki-Minc, E. 1970: Effect of allopurinol on the course of gout. Biological and biochemical properties, metabolism in living organisms, effect on the purine metabolism Polski Tygodnik Lekarski 25(15): 544-546
Mertz, D.P. 1978: The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies Münchener Medizinische Wochenschrift 120(42): 1387-1390
Kratochvílovà, B.; Profant, O.; Astl, J.ír.; Holý, R. 2016: Our experience in the treatment of idiopathic sensorineural hearing loss (ISNHL): Effect of combination therapy with HBO₂ and vasodilator infusion therapy Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 43(7): 771-780
Hioki, M.; Kagawa, S.; Fujiwara, T.; Sakai, R.; Kojima, T.; Watanabe, Y.; Hashimoto, Y.; Uno, F.; Tanaka, N.; Fujiwara, T. 2008: Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy International Journal of Cancer 122(11): 2628-2633
Akamatsu, H.; Tsukuura, T.; Matsunaga, H.; Suzuki, A. 1993: Study of combination therapy for thymoma: a case of stage IV which presented as total spinal block caused by epidural metastasis and which preoperative combination therapy was effective for minimizing the tumor Kyobu Geka. Japanese Journal of Thoracic Surgery 46(13): 1156-1160
Mukai, M.; Ando, K.; Koike, S.; Ishikawa, T.; Ryu, M.; Nagashima, T.; Nagao, K.; Isono, K. 1986: Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 1): 556-562
Iwatani, M.; Nishioka, K. 1991: The prognosis of gout and hyperuricemia--the effect of the treatment on prognosis Nihon Rinsho. Japanese Journal of Clinical Medicine 49(5): 1124-1130
Osbaldiston, G.W.; Lowrey, J.L. 1971: Allopurinol in the prevention of hyperuricemia in Dalmatian dogs Veterinary Medicine-Small Animal Clinician 66(7): 711-715
Soma, I.; Hasuike, Y.; Hayashi, N.; Fukuchi, N.; Izawa, H.; Yoshida, T.; Ebisui, C.; Sakita, I.; Fujimoto, T.; Koshino, T.; Izumiyama, K. 2004: A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1903-1905
Peuke, C. 2010: Hyperuricemia/gout Medizinische Monatsschrift für Pharmazeuten 33(11): 429-432
Hosoya, T. 2008: Gout and hyperuricemia: Introduction Nihon rinsho. Japanese journal of clinical medicine 66(4): 621-623
Beatty, G.; Hunt, P.; Smith, A.; Hoh, R.; Huang, W.; Martin, J.; Deeks, S.G. 2006: A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide Antiviral Therapy 11(3): 315-319